1. ScholarBank@NUS

Wai Keung Chui

rp00117

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wai Keung Chui
Variants
Wai, K.C.
Chui, W.-K.
Chui Wai Keung
Keung Chui, W.
Chui, W.K.
Chui, W.-K.
 
Main Affiliation
 
Faculty
 
Email
phacwk@nus.edu.sg
 

Publications

Refined By:
Department:  PHARMACY
Date Issued:  [2010 TO 2019]
Date Issued:  2012

Results 1-10 of 10 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
11-May-20123D-QSAR Study on dihydro-1,3,5-triazines and their spiro derivatives as DHFR inhibitors by comparative molecular field analysis (CoMFA)Ma, X. ; Xiang, G.; Yap, C.-W. ; Chui, W.-K. 
22012Acute and chronic administrations of rheum palmatum reduced the bioavailability of phenytoin in rats: A new herb-drug interactionChi, Y.-C.; Juang, S.-H.; Chui, W.K. ; Hou, Y.-C.; Chao, P.-D.L.
32012Advances in chemistry and biological activity of fluorinated 1,3,5-triazinesDolzhenko, A.V. ; Dolzhenko, A.V.; Chui, W.-K. 
4Apr-2012Computational prediction of state anxiety in Asian patients with cancer susceptible to chemotherapy-induced nausea and vomitingYap, K.Y.-L.; Low, X.H. ; Chui, W.K. ; Chan, A. 
5Dec-2012Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patientsCheung, Y.T.; Shwe, M.; Chui, W.K. ; Chay, W.Y.; Ang, S.F.; Dent, R.A.; Yap, Y.S.; Lo, S.K.; Ng, R.C.H.; Chan, A. 
6Jul-2012Neuro-cognitive impairment in breast cancer patients: Pharmacological considerationsCheung, Y.T.; Chui, W.K. ; Chan, A. 
715-Dec-2012Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer propertiesSaha, S.; Chan, D.S.Z.; Lee, C.Y.; Wong, W.; New, L.S. ; Chui, W.K. ; Yap, C.W. ; Chan, E.C.Y. ; Ho, H.K. 
821-Jun-2012Regioselective synthesis of pyrimido[1,2-a][1,3,5]triazin-6-ones via reaction of 1-(6-oxo-1,6-dihydropyrimidin-2-yl)guanidines with triethylorthoacetate: Observation of an unexpected rearrangementSachdeva, N.; Dolzhenko, A.V.; Keung Chui, W. 
9Jul-2012Synthesis and structure of 3,4-dihydropyrido[2',3':3,4]pyrazolo[1,5-a][1,3, 5]triazin-2-amines [1]Dolzhenko, A.V.; Bai, S.; Dolzhenko, A.V.; Chui, W.K. 
101-Feb-2012Utilizing mobile networks for the detection of clinically relevant interactions between chemotherapy regimens and complementary and alternative medicinesYap, K.Y.-L.; See, C.S.; Kuo, E.Y.; Chui, W.K. ; Chan, A.